Develop core R&D assets
Decipher a challenging MOA or POC
Decrease investment risk with hands-on validation
GLP Analytical and clinical testing
About Us
Smart Assays has been a key factor in the regulatory submissions and financing rounds of public and private life science companies providing hands-on expertise and tailor-made R&D services for evaluation and validation of early and clinical-stage projects.
Fields of Expertise
Proof-of-Concept of IP
Reproducibility of results
Instrumentation + Assays Development
Develop, Design, Verify and validate
Strength, Specificity and selectivity
Tailored consultation and services
Establish IHC Protocol, analyses, evaluate and score
Novel screening method for production
Intestinal permeability, metabolism solubility, toxicity and cardiotoxicity
FDA and EMA regulations-compliant. SOPs validated in GMP facilities
Identification of specific biomarkers
Single cell proteomics
I have been working with Smart Assays from 2013 on 3 separate programs, as VP R&D and now COO in public and private companies. The first question Smart Assays asks is “What would you like to accomplish” and then they plan and perform an out-of-the-box strategy that gets you there via the shortest possible route. A great example of a hands-on, enterprising spirit that holds its own and deliver faster than larger R&D service providers.
Dori Pelled, Ph.D., COO, IMEL Biotherapeutics Inc.
News and Events
150+ Customers